The stock opened at Rs 1658.6 and touched an intraday high and low of Rs 1684.1 and Rs 1630.2, respectively, in the session so far. Shares of the company of Lupin Ltd. quoted a 52-week high of Rs 1703.8 and a 52-week low of Rs 766.05.
Total market cap of the Lupin Ltd. stood at Rs 76919.22 crore at the time of writing this report.
Key Financials
The company reported consolidated net sales of Rs 4990.04 crore for the quarter ended 31-Mar-2024, down 4.53 per cent from previous quarter’s Rs 5226.78 crore and down 11.7 per cent from the year-ago quarter’s Rs 4467.35 crore.
The net profit for latest quarter stood at Rs 359.43 crore, up 52.33 per cent from the same quarter a year ago.
Shareholding pattern
As of 31-Mar-2024, DIIs held 16.82 per cent stake in the company, while foreign institutional investors held 18.29 per cent and the promoters 47.01 per cent.
Valuation ratio
According to BSE data, the stock traded at a price-to-earnings multiple of 40.44 and a price-to-book ratio of 5.16. A higher P/E ratio shows investors are willing to pay a higher price because of better future growth expectations. Price-to-book value indicates the inherent value of a company and is the measure of the price that investors are ready to pay even for no growth in the business.
Lupin Ltd. belongs to the Pharma – Indian industry.
